Ornitz et al.; Elastase I Promoter Directs Expression of Human Growth Hormone and SV40 T Antigen Genes to Pancreatic Acinar Cells in Transgenic Mice, 1988, Cold Spring Symp.Quart.Bio. 50: 399-409.* |
Miller et.al.; Targeted vectors for gene therapy, 1995, FASEB J. 9: 190-199.* |
Verma et al.; Gene therapy-promises, problems and prospects, 1997, Nature, vol. 389: 239-242.* |
Orkin et.al.; Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy, 1995.* |
Felix, et al.; Pegylated Peptides IV Enhanced Biological Activity of site-directed pegylated GRF analogs; Int. J. Peptide Protein Research; vol. 46 pp. 253-264 (1995). |
Reecy, et al.; Structure and regulation of the porcine skeletal α-actin-encoding gene; GENE 180 pp. 23-28 (1996). |
Kubiak, et al.; Position 2 and Position 2/Ala15 -Substituted Analogs of Bovine Growth Hormone-Releasing Factor (bGRF) with Enhanced Metabolic Stability and Improved in Vivo Bioactivity; J. Med. Chem. vol. 36, pp. 888-897 (1993). |
Breedam, et al.; Amidation of Growth Hormone releasing factor (1-29) by serine carboxypeptidase catalysed transpeptidation; Int. J. Peptide Protein Res.; vol. 37, pp. 153-160 (1991). |
Draghia-Akli, et al; Enhanced growth by ectopic expression of growth hormone releasing hormone using an injectable myogenic vactor; Nature Biotechnology, vol. 15, pp. 1285-1289 (1997). |
Hoffman, et al.; Inhibition of dipeptidyl peptidase IV (DP IV) by anti-DP IV antibodies and non-substrate X-X-Pro- oligopeptides ascertained by capillary electrophoresis; J. of Chromatogrpahy A; vol. 716 pp. 355-362 (1995). |
Brar, et al.; Biosynthesis of Human Growth Hormone-Releasing Hormone (hGRH) in the Pituitary of hGRH Transgenic Mice; (1991) Endocrinolgoy 129:3274-3280. |
Arase, et al.; Effects on Feeding Behavior of Rats of a Cryptic Peptide from the C-Terminal End of Prepro-Growh Hormone-Releasing Factor; (1987) Endocrinology 121: 1960-1965. |
Vance; Growth-Hormone-Releasing Hormone; (1990) Clin. Chem. 36/3: 415-420. |
Frohman, et al.; Dipeptidylpeptidase IV and Trypsin-like Enzymatic Degradation of Human Growth Hormone-releasing Hormone in Plasma; (1989) J. Clin. Invest. 83: 1533-1540. |
Etherton, et al.; Biotogy of Somatotropin in Growth and Lactation of Domestic Animals; (1998) Physiological reviews 78: 745-761. |
Etherton; Growth Hormone Technology Develops New Twist; Nature Biotechnology 15: 1248. |
Benoist, et al.; In Vivo Sequence Requirements of the SV40 Early Promoter Region; (1981) Nature 290: 304-310. |
Yamamoto, et al.; Identification of a Functional Promoter in the Long Terminal Repeat of Rous Sarcoma Virus; (1980) Cell 22: 787-797. |
Wagner, et al.; Nucleotide Sequence of the Thymidine Kinase Gene of Herpes Simplex Virus Type 1; Proc. Natl. Acad. USA 78: 1441-1445. |
Brinster, et al.; Regulation of Metallothionein-Thymidine Kinase Fusion Plasmids Injected into Mouse Eggs; (1982) Nature 296: 39-42. |
Villa-Kamaroff, et al.; A Bacterial Clone Synthesizing Proinsulin; (1978) Proc. Natl. Acad. Sci. USA 75: 3727-3731. |
DeBoer, et al.; The Tac Promoter: A Functional Hybrid Derived from the trp and Iac Promoters; (1983) Proc. Natl. Acad. Sci. USA 80: 21-25. |
Herrera-Estrella, et al.; Expression of Chimaeric Genes Transferred into Plant cell Using a Ti-plasmid-derived Vector; Nature 303: 209-213. |
Herrera-Estrella, et al.; Light-Inductible and Chloroplast-Associated Expression of a Chimaeric Gene Introduced into Nicotiana Tabacum Using a Ti Plasmid Vector; Nature 310: 115-120. |
Gardner, et al.; Abstract; (1981) Nucleic Acid Research; 9: 2871-2888. |
Swift, et al.; Tissue-Specific Expression of the Rat Pancreatic Elastase I Gene in Transgenic Mice; (1984) Cell 38: 639-646. |
Omitz, et al.; Elastase I Promoter Directs Expression of Human Growth Hormone and SV40 T Antigen Genes to Pancreatic Acinar Cells in Transgenic Mice; 1986) Cold Sprin Harbor Symp. Quant. Bio. 50: 399-409. |
McDonald , et al.; Diminished Responsiveness of Male Homosexual Chronic Hepatits B Virus Carriers with HTLV-III Antibodies to Recombinant α-Interferon; (1987) Hepatology 7: 719-723. |
Grosschedl, et al.; Introduction of a μ Immunoglobulin Gene Into the Mouse Gem Line: Specific Expression in Lymphoid Cells and synthesis of Functional Antibody; (1984) 38:647-658. |
J.M. Adams, et al.; The c-myc Onocogene Driven by Immunoglobulin Enhancers Induces Lymphoid Mallgnancy in Transgenic Mice; (1985) Nature 318: 533-538. |
Alexander, et al.; Expression of the c-myc Oncogene Under Control of an Immunoglobulin Enhancer in Eμ-myc Transgenic Mice; (1987) Mol. Cellular Biology; 7: 1436-1444. |
Leder, et al.; Consequences of Widespread Deregulation of the c-myc Gene in Transgenic Mice: Multiple Neoplasms and Normal Development; (1986) Cell 45: 485-495. |
Pinkert, et al.; An Albumin Enhancer Located 10 kb Upstream Functions along with its Promoter to Direct Efficient, Liver-Specific Expression in Transgenic Mice; (1987) Genes and Devel. 1:268-276. |
Krumlauf, et al.; Development Regulation of α-Fetoprotein Genes In Transgenic Mice; (1985) Mol. Cell. Bio. 5: 1639-1648. |
Hammer, et al.; Diversity of Alpha-Fetoprotein Gene Expression in Mice Is Generated by a Combination of Separate Enhancer Elements; (1987) Science 235: 53-58. |
Kelsey, et al.; Species and Tissue-Specific Expression of Human α1-Antitrypsin Mice; (1987) Genes Devel. 1: 161-171. |
Magram, et al.; Developmental Regulation of a Cloned Adult β-Globin Gene in Transgenic Mice; (1985) Nature 315: 338-340. |
Kollias, et al.; Regulated Expression of Human Aγ-, β-, and Hybrid γβ-Globin Genes in Transgenic Mice; Manipulation of the Developmental Expression Patterns; (1986) Cell 46: 89-94. |
Readhead, et al.; Expression of a Myelin Basic Protein Gene In Transgenic Shiverer Mice; Correction of the Dysmyelinating Phenotype; (1987) Cell 48: 703-712. |
Shani; Tissue-Specific Expression of Rat Myosin Light-Chain 2 Gene in Transgenic Mice; (1985) Nature 314: 283-286. |
Reecy, et al.; Multiple Regions of the Porcine α-Skeletal Actin Gene Modulate Muscle-Specific Expression in Cell culture and Directly Injected Skeletal Muscle; (1998) Animal Biotechnology 9: 101-120. |
Mason, et al.; The Hypogonadal Mouse: Reproductive Functions Restored by Gene Therapy: (1986) Science 234: 1372-1378. |
Wigler, et al.; Transfer of Purified Herpes Virus Thymidine Kinase Gene to Cultured Mouse Cells; (1977) Cell 11: 223-232. |
Szybalska & Szybalski; Genetics of Human Cell Lines, IV. DNA-Mediated Heritable Transformation of Biochemical Trait; (1962) Proc. Natl. Acad. Sci. USA 48: 2026. |
Lowy, et al.; Isolation of Transforming DNA: Cloning the Hamster Aprt Gene; (1980) Cell 22: 817-823. |
Wigler, et al.; Transformation of Mammalian with an Amplifiable Dominant-Acting Gene; (1980) Natl. Acad. Sci. 77:3567-3570. |
O'Hare, et al.; Transformation of Mouse Fibroblasts to Methotrexate Resistance by a Recombinant Plasmid Expressing a Prokarytoci Dehydrofolate Reductase; (1981) Proc. Natl. Acad. Sci. USA 78: 1527-1531. |
Mulligan, et al.; Selection for Animal Cells that Express the Escherichia Coli Gene Coding for Xanthine-Guanine Phosphoribosytransferase; (1981) Proc. Natl. Acad. Sci. USA 78: 2072-2076. |
Colbere-Garapin, et al.; A New Dominant Hybrid Selective Marker for Higher Eukaryotic Cells; (1981) J. Mol. Biol. 150: 1-14. |
Santerre, et al.; Expression of Prokaryotic Genes for Hygromycin B and G418 Resistance as Dominant-Selection Markers in Mouse L Cells; (1984) Gene 30: 147-156. |
Goldspiel, et al.; Human Gene Therapy; (1993) Clinical Pharmacy 12: 488-505. |
Wu, et al.; Delivery Systems for Gene Therapy (1991) Biotherapy 3: 87-95. |
Tolstoshev; Gene Therapy, Concepts, Current Trials and Future Directions: (1993) Ann. Rev. Pharmacol. Toxicol. 32: 573-596. |
Mulligan; The Basic Science of Gene Therapy; (1993) Science 260: 926-932. |
Morgan, et al.; Human Gene Therapy; (1993) Annual Rev. Biochem. 62: 191-217. |
Editorial; Gene Therapy—Proceeding from Laboratory to Clinic; (1993) Tibtech 11(5) 155-215. |
Koller, et al.; Inactivating the β2-microglobulin Locus in Mouse Embryonic Stem Cells by Honologous Recombination; (1989) Proc. Natl. Acad. Sci. USA 86: 8932-8935. |
Zijlstra, et al.; Gem-line Transmission of a distrupted β2-microglobulin Gene Produced by Homologous Recomination in Embryonic Stem Cells; (1989) Nature 342: 435-438. |
Wu, et al.; Receptor-Mediated in Vitro Gene Transformation by a Soluble DNA Carrier System; (1987) J. biologcial Chem. 262: 4429-4432. |
Miller, et al.; Use of Retroviral Vectors for Gene Transfer and Expression; (1993) Methods in Enzymology 217: 581-599. |
Boesen, et al.; Circumvention of Chemotherapy-Induced Myelosuppression by Transfer of the mdr1 Gene; (1994) Biotherapy 6: 291-302. |
Clowes, et al.; Long-Term Biological Response of Injured Rat Carotid Artery Seeded with Smooth Muscle Cells Expressing Retrovirally Introduced Human Genes; (1994) J. Clin. Invest. 93: 644-651. |
Kiern, et al.; Retrovirus-Mediated Gene Transduction Into Canine Peripheral Blood repopulating Cells; (1994) Blood 83: 1467-1473. |
Grossman, et al.; Retroviruses: Delivery Vehicle to the Liver; (1993) Current Opin. in Genetics and Devel. 3: 110-114. |
Bout, et al.; Lung Gene Therapy: In Vivo Adenovirus-Mediated Gene Transfer to Rhesus Monkey Airway Epithelium; (1994) Human Gene Therapy 5: 3-10. |
Rosenfeld, et al.; Adenovirus-Mediated Transfer of a Recombinant α1-Antitrypsin Gene to the Lung Epithelium in Vivo; (1991) Science 252: 431-434. |
Rosenfeld, et al.; In Vivo Transfer of the Human Cystic Fibrosis Transmembrane Conductance Regulator Gene to the Airway Epithelium; (1992) Cell 68: 143-155. |
Mastrangeli, et al.; Diversity of Airway Epithelial Cell Targets for in Vivo Recombinant Adenovirus-Mediated Gene Trasnfer; (1993) J. Clin. Investigation 91: 225-234. |
Wang, et al.; A Packaging Cell Line for Propagation of Recombinant Adenovirus Vectors Containing two Lethal Gene-region Deletions; (1995) Gene Therapy 2: 775-783. |
Walsh, et al.; Gene Therapy for Human Hemoglobinopathies; (1993) Proc. Soc. Exp. Biolo. Med. 204: 289-300. |
Loeffler, et al.; Gene Transfer into Primary and Established Mammalian Cell Lines with Lipopolyamine-Coated DNA; (1993) Methods in Enzymology 217: 599-618. |
Cotton, et al.; Receptor-Mediated Transport of DNA into Eukaryotic Cells; (1993) Methods in Enzymol. 217: 618-644. |
Cline; Perspectives for Gene Therapy: Inserting New Genetic Information into Mammalian Cells by Physical Techniques and Viral Vectors; (1985) Pharmac. Ther. 29:69-92. |
Stemple, et al.; Isolation of Stem Cell for Neurons and Glia From the Mammalian Neural Crest; (1992) Cell 71: 973-985. |
Rheinwald; Serial Cultivation of Normal Human Epidermal Keratinocytes; (1980) Methods in Cell Biology 21A: 229-254. |
Pittelkow, et al.; New Techniques for the in Vitro Culture of Human Skin Keratinocytes and Perspectives on Their Use for Grafting of Patients with Extensive Burns; (1986) Mayo Clinc Proc. 61: 771-777. |
Langer; New Methods of Drug Delivery; Science (1990) 249: 1527-1533. |
Treat, et al.; Liposome Encapsulated Doxorubicin Preliminary Results of Phase I and II Trials; Liposomes in the Therapy of Infectious Disease and Cancer (1989) 353-365. |
Lopez-Berestein; Treatment of Systemic Fungal Infections with Liposoml-amphotericin B; Liposomes in the Therapy of Infectious Disease and Cancer; 317-327. |
Sefton; Implantable Pumps; CRC Critical Reviews in Biomed. Engineering 14: 201-240. |
Buchwald, et al.; Long-Term Continuous Intravenous Heparing Administration by an Implantable infusion Pump In Ambulatory Patients with Recurrent Venous Thrombosis; (1980) SUrgery 88: 507-516. |
Saudek, et al.; A Preliminary Trial of the Programmable Implantable Medication System for Insulin Delivery; (1989) The New England J. of Medicine 321: 574-579. |
Langer, et al.; Chemical and Physical Structure of Polymers as Carriers for Controlled Release of Bioactive Agents: A Review; (1983) J. Macromol. Chem. Phys. 23:61-126. |
Abstract, Science 228: (1985) 190-192. |
During, et al.; Controlled Release of Dopamine From a Polymeric Brain Implant in Vivo Characterization; (1989) Ann. Neurol. 25: 351-356. |
Howard, et al.; Intracerbral Drug Delivery in Rats with Lesion-Induced Memory Deficits; (1989) J. Neurosurg. 71: 105-112. |
Goodson; (1984) Dental Applications; Medical Applications of Controlled Release, vol. II 115-138. |
Joliot, Proc. Natl. Acad. Sci, USA (1991) 1864-1868. |